Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Abbott Laboratories, current enterprise value calculation

Microsoft Excel
Current share price (P) $117.13
No. shares of common stock outstanding 1,734,455,213
US$ in millions
Common equity (market value)1 203,157
Add: Preferred shares, one dollar par value, none issued (per books)
Add: Noncontrolling interests in subsidiaries (per books) 224
Total equity 203,381
Add: Short-term borrowings (per books)
Add: Current portion of long-term debt (per books) 1,080
Add: Long-term debt, excluding current portion (per books) 13,599
Total equity and debt 218,060
Less: Cash and cash equivalents 6,896
Less: Investments, primarily bank time deposits and U.S. treasury bills 383
Enterprise value (EV) 210,781

Based on: 10-K (reporting date: 2023-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 117.13 × 1,734,455,213


Historical Enterprise Value (EV)

Abbott Laboratories, EV calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Share price1, 2 $114.01 $106.74 $116.79 $123.04 $87.45
No. shares of common stock outstanding1 1,735,184,289 1,737,946,233 1,763,482,267 1,771,529,358 1,763,433,243
US$ in millions
Common equity (market value)3 197,828 185,508 205,957 217,969 154,212
Add: Preferred shares, one dollar par value, none issued (book value)
Add: Noncontrolling interests in subsidiaries (book value) 224 219 222 219 213
Total equity 198,052 185,727 206,179 218,188 154,425
Add: Short-term borrowings (book value) 213 201
Add: Current portion of long-term debt (book value) 1,080 2,251 754 7 1,277
Add: Long-term debt, excluding current portion (book value) 13,599 14,522 17,296 18,527 16,661
Total equity and debt 212,731 202,500 224,229 236,935 172,564
Less: Cash and cash equivalents 6,896 9,882 9,799 6,838 3,860
Less: Investments, primarily bank time deposits and U.S. treasury bills 383 288 450 310 280
Enterprise value (EV) 205,452 192,330 213,980 229,787 168,424

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Abbott Laboratories Annual Report.

3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 114.01 × 1,735,184,289

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Abbott Laboratories EV decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.